Abstract
SARS-CoV-2 is a novel coronavirus that expanded worldwide, generating a pandemic of acute respiratory syndrome called “coronavirus disease 2019” (COVID-19), which resulted in a global health crisis. The spectrum of COVID-19 manifestations ranges from none or mild symptoms to severe respiratory failure associated with systemic manifestations, mostly gastrointestinal symptoms. Hypercoagulability is an important feature of COVID-19 disease, which can potentially influence patients’ prognosis. Therefore, gastroenterologists should focus on subjects with concomitant hypercoagulable gastrointestinal disorders as they may display a higher risk of thrombotic complications during SARS-CoV-2 infection. The aim of this review is to summarize the available evidence regarding the interplay of the prothrombotic pathogenetic mechanisms of both COVID-19 and hypercoagulable digestive diseases and the possible clinical implications. We summarized the potential interplay of prothrombotic mechanisms of both COVID-19 and hypercoagulable digestive diseases in the graphical abstract.
Keywords: Coronavirus disease 2019, SARS-CoV-2, hypercoagulable status, thromboembolism, inflammatory bowel disease, chronic liver disease, coeliac disease.
Current Drug Targets
Title:Gastrointestinal System: COVID-19 and Potential Mechanisms Associated with Coagulopathy
Volume: 23 Issue: 17
Author(s): Federica Furfaro, Roberto Gabbiadini, Ferdinando D’Amico, Alessandra Zilli, Arianna Dal Buono, Mariangela Allocca, Gionata Fiorino and Silvio Danese*
Affiliation:
- Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy
- University Vita-Salute San Raffaele, Milan, Italy
Keywords: Coronavirus disease 2019, SARS-CoV-2, hypercoagulable status, thromboembolism, inflammatory bowel disease, chronic liver disease, coeliac disease.
Abstract: SARS-CoV-2 is a novel coronavirus that expanded worldwide, generating a pandemic of acute respiratory syndrome called “coronavirus disease 2019” (COVID-19), which resulted in a global health crisis. The spectrum of COVID-19 manifestations ranges from none or mild symptoms to severe respiratory failure associated with systemic manifestations, mostly gastrointestinal symptoms. Hypercoagulability is an important feature of COVID-19 disease, which can potentially influence patients’ prognosis. Therefore, gastroenterologists should focus on subjects with concomitant hypercoagulable gastrointestinal disorders as they may display a higher risk of thrombotic complications during SARS-CoV-2 infection. The aim of this review is to summarize the available evidence regarding the interplay of the prothrombotic pathogenetic mechanisms of both COVID-19 and hypercoagulable digestive diseases and the possible clinical implications. We summarized the potential interplay of prothrombotic mechanisms of both COVID-19 and hypercoagulable digestive diseases in the graphical abstract.
Export Options
About this article
Cite this article as:
Furfaro Federica, Gabbiadini Roberto, D’Amico Ferdinando, Zilli Alessandra, Dal Buono Arianna, Allocca Mariangela, Fiorino Gionata and Danese Silvio*, Gastrointestinal System: COVID-19 and Potential Mechanisms Associated with Coagulopathy, Current Drug Targets 2022; 23 (17) . https://dx.doi.org/10.2174/1389450123666220922095913
DOI https://dx.doi.org/10.2174/1389450123666220922095913 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response and/or therapy ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Amino Acid-Substituted Gemini Surfactant-Based Nanoparticles as Safe and Versatile Gene Delivery Agents
Current Drug Delivery Calcium Ion – The Key Player in Cerebral Ischemia
Current Medicinal Chemistry Genitourinary Complications of Diabetes Mellitus: An Overview of Pathogenesis, Evaluation, and Management
Current Diabetes Reviews Laccases in Pharmaceutical Chemistry: A Comprehensive Appraisal
Mini-Reviews in Organic Chemistry Nanoformulations Enabled Possible Solutions for the Management of Psoriasis
Current Cosmetic Science Osteoprotegerin and Osteopontin Serum Levels are Associated with Vascular Function and Inflammation in Coronary Artery Disease Patients
Current Vascular Pharmacology Comparison and Impact of The Short-Term Use of Some Non-Aspirin NSAIDs on Bleeding Time of Mice
Cardiovascular & Hematological Agents in Medicinal Chemistry New Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
Current Pharmaceutical Biotechnology Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy
Current Diabetes Reviews Ethanol Metabolism and Effects: Nitric Oxide and its Interaction
Current Clinical Pharmacology Aetiology, Diagnosis and Treatment of Hydrops Foetalis
Current Pediatric Reviews Adeno-associated Virus 9-mediated Small RNA Interference of TLR4 Alleviates Myocardial Ischemia and Reperfusion Injury by Inhibition of the NF-κB and MAPK Signaling Pathways in Rats
Current Molecular Medicine Impact of Leukemia Stem Cells Phenotype Expression on Response to Induction Therapy in Acute Myeloid Leukemia Patients
Cardiovascular & Hematological Disorders-Drug Targets Assays for Histone Deacetylases
Current Topics in Medicinal Chemistry 2-Arylquinazolin-4(3H)-ones: Inhibitory Activities Against Xanthine Oxidase
Medicinal Chemistry Molecular Dissection of Renal Ischemia-Reperfusion: Oxidative Stress and Cellular Events
Current Medicinal Chemistry Thrombocytopenia in HIV Disease: Clinical Relevance, Physiopathology and Management
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Systems Genomics Support for Immune and Inflammation Hypothesis of Depression
Current Neuropharmacology SARS: Understanding the Virus and Development of Rational Therapy
Current Molecular Medicine Adenovirus-based Immunotherapy for Prostate Cancer
Current Cancer Therapy Reviews